A
$ Value
$0
Shares
14,166
Price
$0
Filed
May 1
Insider
Name
Li Dean Y
Title
Executive VP & President, MRL
CIK
0001837016
Roles
Officer
Transaction Details
Transaction Date
2025-04-29
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
14,166
Footnotes
Holdings include shares acquired in dividend reinvestment transactions. | Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. | These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028. | The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
Filing Info
Li Dean Y's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | RXRX | A | $0 |
| 2025-10-01 | RXRX | A | $0 |
| 2025-07-01 | RXRX | A | $0 |
| 2025-06-18 | RXRX | A | $0 |
| 2025-06-18 | RXRX | A | $0 |
| 2025-04-29 | MRK | A | $0 |
| 2025-04-29 | MRK | A | $0 |
Other Insiders at MRK (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GLOCER THOMAS H | — | — | 2026-03-31 |
| Coe Mary Ellen | — | — | 2026-03-31 |
| Seidman Christine E | — | — | 2026-03-31 |